Overview

Study of Induction Docetaxel, Cisplatin and 5-Fluorouracil

Status:
Terminated
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This is a Phase II study designed to test the efficacy of chemotherapy with docetaxel, cisplatinum (cisplatin) and 5-fluorouracil in patients with squamous cell carcinoma of the oral cavity to determine what effects these agents may have on cancer cells.
Phase:
Phase 2
Details
Lead Sponsor:
Emory University
Collaborator:
Sanofi
Treatments:
Cisplatin
Docetaxel
Fluorouracil